Relation Therapeutics

Relation Therapeutics integrates single-cell multi-omics from patient tissue with functional assays and machine learning to discover causal genes and validate therapeutic targets. The London-based company secured a landmark $1.7B Novartis collaboration for atopic diseases in December 2025, along with a $26M investment from NVIDIA, adding to an earlier GSK partnership for fibrotic diseases.

$130M+

Total raised

Lab-in-the-Loop platform using single-cell multi-omics from patient tissue, functional assays, and ML to discover causal genes and validate therapeutic targets. Generates proprietary biological datasets that continuously improve AI models.